Cardlytics (NASDAQ:CDLX) Insider Nicholas Hollmeyer Lynton Sells 6,098 Shares

Key Points

• Nicholas Hollmeyer Lynton, an insider at Cardlytics, sold 6,098 shares at an average price of $2.27, reducing his position by 4.98% to 116,327 shares.
• Cardlytics' shares are currently trading at $2.37, with a market cap of $126.18 million and a year-to-date price range of $0.85 to $5.24.
• Evercore ISI has downgraded the price target for Cardlytics from $3.00 to $2.00, while the stock holds an average rating of "Moderate Buy."

Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) insider Nicholas Hollmeyer Lynton sold 6,098 shares of the firm's stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $2.27, for a total transaction of $13,842.46. Following the completion of the sale, the insider owned 116,327 shares of the company's stock, valued at $264,062.29. The trade was a 4.98% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.

Cardlytics Trading Up 0.4%

Shares of NASDAQ CDLX traded up $0.01 during mid-day trading on Thursday, hitting $2.37. The company's stock had a trading volume of 3,685,673 shares, compared to its average volume of 13,037,717. The stock has a market cap of $126.18 million, a price-to-earnings ratio of -0.65 and a beta of 1.45. The company has a debt-to-equity ratio of 2.87, a current ratio of 1.16 and a quick ratio of 1.16. Cardlytics, Inc. has a one year low of $0.85 and a one year high of $5.24. The company's fifty day simple moving average is $1.58 and its 200-day simple moving average is $1.73.

Hedge Funds Weigh In On Cardlytics

A number of institutional investors have recently added to or reduced their stakes in the company. Catalyst Funds Management Pty Ltd bought a new position in Cardlytics during the second quarter worth $32,000. Post Resch Tallon Group Inc. boosted its stake in shares of Cardlytics by 100.0% in the 2nd quarter. Post Resch Tallon Group Inc. now owns 20,000 shares of the company's stock valued at $33,000 after purchasing an additional 10,000 shares in the last quarter. Sand Hill Global Advisors LLC bought a new position in Cardlytics in the 2nd quarter valued at approximately $35,000. Jump Financial LLC bought a new position in Cardlytics during the 1st quarter worth approximately $41,000. Finally, Y Intercept Hong Kong Ltd acquired a new stake in shares of Cardlytics during the 2nd quarter worth approximately $42,000. 68.10% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Separately, Evercore ISI cut their price target on shares of Cardlytics from $3.00 to $2.00 and set an "in-line" rating on the stock in a research note on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $2.25.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.